Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024
Compare Profit and Loss Results of Bajaj Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
549.00
-7.00
-1.28%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
549.00
-7.00
-1.28%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-10.00
-10.00
-100.00%
Raw Materials Consumed
307.00
295.00
12.00
4.07%
Power & Fuel Cost
22.00
13.00
9.00
69.23%
Employee Cost
57.00
115.00
-58.00
-50.43%
Operating Expenses
63.00
36.00
27.00
75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
51.00
-45.00
-88.24%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
13.00
-7.00
-53.85%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
562.00
-102.00
-18.15%
Operating Profit (PBDIT) excl Other Income
82.00
-12.00
94.00
783.33%
Other Income
19.00
81.00
-62.00
-76.54%
Operating Profit (PBDIT)
101.00
68.00
33.00
48.53%
Interest
27.00
2.00
25.00
1,250.00%
Profit before Depriciation and Tax
73.00
65.00
8.00
12.31%
Depreciation
27.00
24.00
3.00
12.50%
Profit Before Taxation & Exceptional Items
46.00
40.00
6.00
15.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
264.00
-218.00
-82.58%
Provision for Tax
3.00
8.00
-5.00
-62.50%
Profit After Tax
42.00
256.00
-214.00
-83.59%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
-398.00
665.00
167.09%
Profit Available for appropriations
310.00
-142.00
452.00
318.31%
Appropriations
310.00
-142.00
452.00
318.31%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
13.29
38.08
-24.79
-65.10%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024
